Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (2597)	11/18/1997 5:06:00 PM
From: Don Dunlap	Read Replies (1) \| Respond to of 23519

TA warned us about Zonagen a while back. I don't have the post, but he did tell us that "Zonagen does not possess a patent on the Vasomax formulation". Hmmmm. Maybe more on the thread should listen to him. I hope the rest of his predictions hold true!!

To: Zebra 365 who wrote (2597)	11/18/1997 6:33:00 PM
From: Vol	Read Replies (1) \| Respond to of 23519

If ZONA is dead meat, what is VVUS?? Zonagen gets terrible news this AM. ZONA AND VVUS close down 3%. What's up with that! If Vivus got news like that, it would be 15. Compare the chart of ZONA with VVUS. ZONA with neg earnings is more than triple what it was a year ago. VVUS with incredible earnings GROWTH has gone from 17 to 22 in a year. What the #%^&$*@ am I missing?? Perplexed, Vol P.S. Could someone please recap the CNBC discussion.